iwNHL 2015 | Determining effective combinations of immune checkpoint inhibitors for lymphoma

Stephen Ansell

At the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2015 meeting, Stephen M. Ansell, MD, PhD, of Mayo Clinic, Rochester, MN, discusses the clinical development of combination approaches with immune checkpoint inhibitors for the treatment of patients with non-Hodgkin and Hodgkin lymphoma. Challenges and directions for future trials with this approach are also proposed.

Share this video